The effect of topical minoxidil plus betamethasone on androgenetic alopecia
Phase 3
- Conditions
- Androgenetic Alopecia.male-pattern baldness
- Registration Number
- IRCT2016031727095N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
Inclusion Criteria: Androgenetic alopecia; Age 25 and more; Age less than 40
Exclusion criteria: using of corticosteroids; NSAIDs; Cytotoxic agents; topical antiseptics and anti fungals; vasodilators; antibiotics; anti hypertensive medications; diuretics; spirnolactone; cimetidine; cyclosporin; finasteride; ketoconazole
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hair growing. Timepoint: 2 months. Method of measurement: Trichoscopy.
- Secondary Outcome Measures
Name Time Method